Article Image
News Link • Science, Medicine and Technology

Cancer Blocker Begins Clinical Trials

• arclein
when ribosome biogenesis is dysregulated, proteins are overproduced, creating rampant cell growth, a hallmark of cancer; and abnormalities of the nucleolus, the site of ribosome biogenesis, have been used as an indicator of cancer for over 100 years.”

Join us on our Social Networks:


Share this page with your friends on your favorite social network: